Amicus Therapeutics Opens Global Research and Gene Therapy Center of Excellence

Published 3-19-2020
  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence
  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence
  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence
  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence
  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence

    Courtesy of Amicus Therapeutics.

  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence

    Courtesy of Amicus Therapeutics.

  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence

    Courtesy of Amicus Therapeutics.

  • Amicus Therapeutics - Global Research and Gene Therapy Center of Excellence

    Courtesy of Amicus Therapeutics.

Amicus Therapeutics opened the $25 million Global Research and Gene Therapy Center of Excellence in March of 2020 in Philadelphia. Accommodating up to 200 employees, the 75,000-sf project provides collaborative labs and offices to support the discovery and development of new therapies for rare metabolic diseases. Acting as the headquarters for Amicus' global science organization, the leased facility is located on the top three floors of a 14-story building at uCity Square, a mixed-use knowledge community offering 6.5 million sf of office, laboratory, clinical, residential, and retail space.